Overdose with venlafaxine may be associated with a higher risk of fatal outcome compared to overdose with selective serotonin reuptake inhibitor antidepressants, but lower than that seen with tricyclic antidepressants.
Merck Frosst is introducing a new strength of Fosavance (alendronate sodium/cholecalciferol) that contains a higher amount of cholecalciferol (vitamin D3).
Health Canada is advising consumers and healthcare professionals about the rare, but potentially serious risk to infants when women take codeine-containing products while breastfeeding.
Celgene's Revlimid (lenalidomide 15 mg and 25 mg capsules) is now indicated for the treatment of multiple myeloma (in combination with dexamethasone) in patients who have received at least one prior therapy.
